Former FDA vaccine chief Peter Marks joins Eli Lilly amid concerns over pharma-government “revolving door” Former FDA vaccine chief Dr. Peter Marks, instrumental in fast-tracking experimental COVID-19 vaccines, joined Eli Lilly as a senior executive, reigniting concerns about regulators transitioning to lucrative industry roles and compromising public trust in vaccine safety and efficacy. Marks’ departure mirrors longstanding patterns. Former FDA leaders, including Patrizia Cavazzoni (now at Pfizer) and Scott Gottlieb (Pfizer board member), have shifted to pharmaceutical jobs, enabling conflicts of interest and eroding faith in the agency’s independence from Big Pharma’s profit-driven agendas. Marks admitted the fourth COVID booster was…

Newswire

Features

The Latest